ATARA BIOTHERAPEUTICS INC (ATRA) Earnings History & Surprises
NASDAQ:ATRA • US0465132068
6.385 USD
-0.52 (-7.46%)
Last: Mar 13, 2026, 02:24 PM
Past quarterly earnings results for ATARA BIOTHERAPEUTICS INC (ATRA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 13, 2026
PeriodQ4 / 2025
EPS Estimate-$0.30
Revenue Estimate2.547M
Last Reported
Release DateMar 2, 2026
PeriodQ3 / 2025
EPS Reported-$0.32
EPS Surprise 63.52%
Revenue Surprise 142.15%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.32 | -0.88 | 63.52% | 89.08% | 3.453M | 1.426M | 142.15% | -91.41% |
| Q2 2025 | 0.19 | -0.47 | 140.49% | 106.13% | 17.575M | 7.497M | 134.43% | -38.63% |
| Q1 2025 | 3.50 | -2.02 | 273.33% | 160.87% | 98.149M | 5.78M | 1,598.08% | 258.77% |
| Q4 2024 | -1.19 | -3.65 | 67.38% | 91.50% | 32.753M | 19.531M | 67.70% | 670.30% |
| Q3 2024 | -2.93 | -1.97 | -48.64% | 82.24% | 40.19M | 35.871M | 12.04% | 1,779.79% |
| Q2 2024 | -3.10 | -1.59 | -94.51% | 81.76% | 28.64M | 40.79M | -29.79% | 2,892.69% |
| Q1 2024 | -5.75 | -6.54 | 12.03% | 68.06% | 27.357M | 25.184M | 8.63% | 2,131.40% |
| Q4 2023 | -14.00 | -12.29 | -13.90% | 22.22% | 4.252M | 11.783M | -63.91% | 1,832.73% |
| Q3 2023 | -16.50 | -16.88 | 2.26% | 19.51% | 2.138M | 4.853M | -55.94% | -52.06% |
| Q2 2023 | -17.00 | -17.15 | 0.85% | -119.35% | 957K | 3.843M | -75.10% | -98.14% |
| Q1 2023 | -18.00 | -9.99 | -80.21% | 17.24% | 1.226M | 31.291M | -96.08% | -83.23% |
| Q4 2022 | -18.00 | -12.95 | -39.04% | 25.00% | 220K | 40.466M | -99.46% | -97.09% |
| Q3 2022 | -20.50 | -20.02 | -2.41% | 8.89% | 4.46M | 5.381M | -17.12% | -16.95% |
| Q2 2022 | -7.75 | -23.61 | 67.18% | 65.93% | 51.58M | 6.974M | 639.60% | 1,232.82% |
| Q1 2022 | -21.75 | -24.99 | 12.98% | -1.16% | 7.31M | 5.011M | 45.88% | 105.92% |
| Q4 2021 | -24.00 | -17.48 | -37.30% | -1.05% | 7.55M | 35.846M | -78.94% | - |
| Q3 2021 | -22.50 | -23.90 | 5.85% | 2.17% | 5.37M | 4M | 34.25% | - |
| Q2 2021 | -22.75 | -22.74 | -0.05% | 20.18% | 3.87M | 3.918M | -1.23% | - |
| Q1 2021 | -21.50 | -23.47 | 8.39% | 28.33% | 3.55M | 1.629M | 117.93% | - |
| Q4 2020 | -23.75 | -18.98 | -25.13% | - | 13.6M | -100.00% | - | |
| Q3 2020 | -23.00 | -27.71 | 17.01% | - | - | - | ||
| Q2 2020 | -28.50 | -30.16 | 5.50% | - | - | - | ||
| Q1 2020 | -30.00 | -36.07 | 16.82% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
136.18%
Max EPS beat (4)
273.33%
Min EPS beat (4)
63.52%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
485.59%
Max Revenue beat (4)
1,598.08%
Min Revenue beat (4)
67.70%
Analysis
In the last 4 quarters, ATRA has consistently beaten EPS estimates in all releases
ATRA has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ATRA has beaten the EPS estimates by 136.2% on average.
In the last 4 quarters, ATRA has beaten the revenue estimates by 485.6% on average.
ATARA BIOTHERAPEUTICS INC / ATRA Earnings FAQ
Can you provide the last earnings date for ATARA BIOTHERAPEUTICS INC?
ATARA BIOTHERAPEUTICS INC (ATRA) last reported earnings on 3/2/2026.
Did ATARA BIOTHERAPEUTICS INC (ATRA) beat earnings estimates last quarter?
ATARA BIOTHERAPEUTICS INC (ATRA) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does ATARA BIOTHERAPEUTICS INC (ATRA) beat earnings estimates?
In the last 4 quarters, ATARA BIOTHERAPEUTICS INC (ATRA) has beaten EPS estimates in 4 out of 4 releases.